Thirst for drink brands

A £1 billion ($1.4 billion) bidding war for Lucozade and Ribena is brewing with a raft of private equity firms considering offers. Pharmaceutical giant GlaxoSmithKline last month signalled it wanted to offload the brands.

A £1 billion ($1.4 billion) bidding war for Lucozade and Ribena is brewing with a raft of private equity firms considering offers. Pharmaceutical giant GlaxoSmithKline last month signalled it wanted to offload the brands.

Want access to our latest research and new buy ideas?

Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.

Sign up for free

Related Articles